Overexpression of Tbx3 Predicts Poor Prognosis of Patients with Resectable Pancreatic Carcinoma |
Wang, Hong-Cheng
(Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University)
Meng, Qing-Cai (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University) Shan, Ze-Zhi (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University) Yuan, Zhou (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University) Huang, Xin-Yu (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University) |
1 | Ansari D, Rosendahl A, Elebro J, et al (2011). Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg, 98, 1041-55. DOI |
2 | Ballim RD, Mendelsohn C, Papaioannou VE, et al (2012). The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development. Mol Biol Cell, 23, 2362-72. DOI |
3 | Begum S, Papaioannou VE (2011). Dynamic expression of Tbx2 and Tbx3 in developing mouse pancreas. Gene Expr Patterns, 11, 476-83. DOI |
4 | Carlson H, Ota S, Song Y, et al (2002). Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene, 21, 3827-35. DOI |
5 | Cavard C, Audebourg A, Letourneur F, et al (2009). Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas. J Pathol, 218, 201-9. DOI |
6 | Chapman DL, Garvey N, Hancock S, et al (1996). Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev Dyn, 206, 379-90. DOI |
7 | Du HF, Ou LP, Yang X, et al (2014). A new PKCalpha/beta/TBX3/E-cadherin pathway is involved in PLCepsilonregulated invasion and migration in human bladder cancer cells. Cell Signal, 26, 580-93. DOI |
8 | Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403. DOI ScienceOn |
9 | Fillmore CM, Gupta PB, Rudnick JA, et al (2010). Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A, 107, 21737-42. DOI |
10 | Hansel DE, Rahman A, House M, et al (2004). Met protooncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in welldifferentiated pancreatic endocrine neoplasms. Clin Cancer Res, 10, 6152-8. DOI |
11 | Hidalgo M (2010). Pancreatic cancer. N Engl J Med, 362, 1605-17. DOI |
12 | Li D, Xie K, Wolff R, et al (2004). Pancreatic cancer. Lancet, 363, 1049-57. DOI |
13 | Howard B, Ashworth A (2006). Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet, 2, 112. DOI ScienceOn |
14 | Ito A, Asamoto M, Hokaiwado N, et al (2005). Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett, 219, 105-12. DOI |
15 | Kim J, Chu J, Shen X, et al (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell, 132, 1049-61. DOI |
16 | Li J, Weinberg MS, Zerbini L, et al (2013). The oncogenic TBX3 is a downstream target and mediator of the TGF-beta1 signaling pathway. Mol Biol Cell, 24, 3569-76. DOI |
17 | Lomnytska M, Dubrovska A, Hellman U, et al (2006). Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. Int J Cancer, 118, 412-21. DOI |
18 | Lyng H, Brovig RS, Svendsrud DH, et al (2006). Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics, 7, 268. DOI |
19 | Minguillon C, Logan M (2003). The comparative genomics of T-box genes. Brief Funct Genomic Proteomic, 2, 224-33. DOI |
20 | Mowla S, Pinnock R, Leaner VD, et al (2011). PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration. Biochem J, 433, 145-53. DOI |
21 | Muller CW, Herrmann BG (1997). Crystallographic structure of the T domain-DNA complex of the Brachyury transcription factor. Nature, 389, 884-8. DOI |
22 | Rowley M, Grothey E, Couch FJ (2004). The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia, 9, 109-18. DOI |
23 | Peres J, Davis E, Mowla S, et al (2010). The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process. Genes Cancer, 1, 272-82. DOI |
24 | Renard CA, Labalette C, Armengol C, et al (2007). Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res, 67, 901-10. DOI |
25 | Rodriguez M, Aladowicz E, Lanfrancone L, et al (2008). Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res, 68, 7872-81. DOI |
26 | Schmalhofer O, Brabletz S, Brabletz T (2009). E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev, 28, 151-66. DOI |
27 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
28 | Washkowitz AJ, Gavrilov S, Begum S, et al (2012). Diverse functional networks of Tbx3 in development and disease. Wiley Interdiscip Rev Syst Biol Med, 4, 273-83. DOI |
29 | Winter JM, Yeo CJ, Brody JR (2013). Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol, 107, 15-22. DOI |
30 | Yan W, Cao QJ, Arenas RB, et al (2010). GATA3 inhibits breast cancer metastasis through the reversal of epithelialmesenchymal transition. J Biol Chem, 285, 14042-51. DOI |
31 | Zhang JF, He ML, Qi D, et al (2011). Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression. Integr Cancer Ther, 10, 85-91. DOI |
![]() |